| Literature DB >> 20298245 |
Grzegorz Wegrzyn1, Joanna Jakóbkiewicz-Banecka, Magdalena Gabig-Cimińska, Ewa Piotrowska, Magdalena Narajczyk, Anna Kloska, Marcelina Malinowska, Dariusz Dziedzic, Izabela Gołebiewska, Marta Moskot, Alicja Wegrzyn.
Abstract
Genistein [4',5,7-trihydroxyisoflavone or 5,7-dihydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one] is a natural isoflavone occurring in many plants known to possess various biological activities, ranging from phyto-oestrogenic to antioxidative actions. Recent studies indicated that this isoflavone can also be considered as a drug for as yet untreatable genetic diseases. In the present review, we discuss a plausible use of genistein in treatment of two genetic disorders: CF (cystic fibrosis) and MPS (mucopolysaccharidosis). Although various biological actions of genistein are employed in these two cases, in vitro studies, tests on animal models and pilot clinical trials suggest that this plant-derived compound might be a real hope for patients suffering from severe inherited disorders with relatively complicated pathomechanisms, including those affecting the central nervous system.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20298245 DOI: 10.1042/BST0380695
Source DB: PubMed Journal: Biochem Soc Trans ISSN: 0300-5127 Impact factor: 5.407